Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma (original) (raw)

• Ando S, Sarlis NJ, Krishnan J, Feng X, Refetoff S, Zhang MQ et al. (2001a). Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol Endocrinol 15: 1529–1538.
  Article CAS PubMed Google Scholar
• Ando S, Sarlis NJ, Oldfield EH, Yen PM . (2001b). Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab 86: 5572–5576.
  CAS PubMed Google Scholar
• Brinckerhoff CE, Matrisian LM . (2002). Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3: 207–214.
  Article CAS PubMed Google Scholar
• Chen HW, Privalsky ML . (1993). The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms. Mol Cell Biol 13: 5970–5980.
  Article CAS PubMed PubMed Central Google Scholar
• Davis PJ, Leonard JL, Davis FB . (2008). Mechanisms of nongenomic actions of thyroid hormone. Front Neuroendocrinol 29: 211–218.
  Article CAS PubMed Google Scholar
• Fagin JA . (2002). Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid. Mol Endocrinol 16: 903–911.
  CAS PubMed Google Scholar
• Forrest D, Erway LC, Ng L, Altschuler R, Curran T . (1996a). Thyroid hormone receptor beta is essential for development of auditory function. Nat Genet 13: 354–357.
  Article CAS PubMed Google Scholar
• Forrest D, Hanebuth E, Smeyne RJ, Everds N, Stewart CL, Wehner JM et al. (1996b). Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: evidence for tissue-specific modulation of receptor function. EMBO J 15: 3006–3015.
  Article CAS PubMed PubMed Central Google Scholar
• Forrest D, Vennstrom B . (2000). Functions of thyroid hormone receptors in mice. Thyroid 10: 41–52.
  Article CAS PubMed Google Scholar
• Furumoto H, Ying H, Chandramouli GV, Zhao L, Walker RL, Meltzer PS et al. (2005). An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis. Mol Cell Biol 25: 124–135.
  Article CAS PubMed PubMed Central Google Scholar
• Furuya F, Lu C, Guigon CJ, Cheng SY . (2009). Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors. Steroids 74: 628–634.
  Article CAS PubMed Google Scholar
• Garcia-Silva S, Aranda A . (2004). The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation. Mol Cell Biol 24: 7514–7523.
  Article CAS PubMed PubMed Central Google Scholar
• Gothe S, Wang Z, Ng L, Kindblom JM, Barros AC, Ohlsson C et al. (1999). Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev 13: 1329–1341.
  Article CAS PubMed PubMed Central Google Scholar
• Guigon CJ, Zhao L, Lu C, Willingham MC, Cheng SY . (2008). Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor. Mol Cell Biol 28: 4598–4608.
  Article CAS PubMed PubMed Central Google Scholar
• Heaney AP, Nelson V, Fernando M, Horwitz G . (2001). Transforming events in thyroid tumorigenesis and their association with follicular lesions. J Clin Endocrinol Metab 86: 5025–5032.
  Article CAS PubMed Google Scholar
• Herwig S, Strauss M . (1997). The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem 246: 581–601.
  Article CAS PubMed Google Scholar
• Kamiya Y, Puzianowska-Kuznicka M, McPhie P, Nauman J, Cheng SY, Nauman A . (2002). Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma. Carcinogenesis 23: 25–33.
  Article CAS PubMed Google Scholar
• Kaneshige M, Kaneshige K, Zhu X, Dace A, Garrett L, Carter TA et al. (2000). Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci USA 97: 13209–13214.
  Article CAS PubMed PubMed Central Google Scholar
• Kato Y, Ying H, Willingham MC, Cheng SY . (2004). A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis. Endocrinology 145: 4430–4438.
  Article CAS PubMed Google Scholar
• Kato Y, Ying H, Zhao L, Furuya F, Araki O, Willingham MC et al. (2006). PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway. Oncogene 25: 2736–2747.
  Article CAS PubMed Google Scholar
• Kim CS, Ying H, Willingham MC, Cheng SY . (2007). The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer. Carcinogenesis 28: 932–939.
  Article CAS PubMed Google Scholar
• Kim DS, Franklyn JA, Boelaert K, Eggo MC, Watkinson JC, McCabe CJ . (2006). Pituitary tumor transforming gene (PTTG) stimulates thyroid cell proliferation via a vascular endothelial growth factor/kinase insert domain receptor/inhibitor of DNA binding-3 autocrine pathway. J Clin Endocrinol Metab 91: 4603–4611.
  Article CAS PubMed Google Scholar
• Kim DS, McCabe CJ, Buchanan MA, Watkinson JC . (2003). Oncogenes in thyroid cancer. Clin Otolaryngol Allied Sci 28: 386–395.
  Article CAS PubMed Google Scholar
• Lawal O, Agbakwuru A, Olayinka OS, Adelusola K . (2001). Thyroid malignancy in endemic nodular goitres: prevalence, pattern and treatment. Eur J Surg Oncol 27: 157–161.
  Article CAS PubMed Google Scholar
• Ledent C, Dumont JE, Vassart G, Parmentier M . (1992). Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J 11: 537–542.
  Article CAS PubMed PubMed Central Google Scholar
• Li Z, Meng ZH, Chandrasekaran R, Kuo WL, Collins CC, Gray JW et al. (2002). Biallelic inactivation of the thyroid hormone receptor beta1 gene in early stage breast cancer. Cancer Res 62: 1939–1943.
  CAS PubMed Google Scholar
• Lin KH, Shieh HY, Chen SL, Hsu HC . (1999). Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells. Mol Carcinog 26: 53–61.
  Article CAS PubMed Google Scholar
• Maeda K, Chung YS, Takatsuka S, Ogawa Y, Sawada T, Yamashita Y et al. (1995). Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 13: 477–481.
  Article CAS PubMed Google Scholar
• Martinez-Iglesias O, Garcia-Silva S, Tenbaum SP, Regadera J, Larcher F, Paramio JM et al. (2009). Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis. Cancer Res 69: 501–509.
  Article CAS PubMed Google Scholar
• McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS et al. (2002). Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab 87: 4238–4244.
  Article CAS PubMed Google Scholar
• Meier CA, Dickstein BM, Ashizawa K, McClaskey JH, Muchmore P, Ransom SC et al. (1992). Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3′-triiodothyronine receptors from four families with generalized resistance to thyroid hormone. Mol Endocrinol 6: 248–258.
  CAS PubMed Google Scholar
• Michiels FM, Caillou B, Talbot M, Dessarps-Freichey F, Maunoury MT, Schlumberger M et al. (1994). Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice. Proc Natl Acad Sci USA 91: 10488–10492.
  Article CAS PubMed PubMed Central Google Scholar
• Miyakawa M, Tsushima T, Murakami H, Wakai K, Isozaki O, Takano K . (2003). Increased expression of phosphorylated p70S6 kinase and Akt in papillary thyroid cancer tissues. Endocr J 50: 77–83.
  Article CAS PubMed Google Scholar
• Pei L, Melmed S . (1997). Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 11: 433–441.
  Article CAS PubMed Google Scholar
• Persad S, Dedhar S . (2003). The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastasis Rev 22: 375–384.
  Article CAS PubMed Google Scholar
• Puzianowska-Kuznicka M, Krystyniak A, Madej A, Cheng SY, Nauman J . (2002). Functionally impaired TR mutants are present in thyroid papillary cancer. J Clin Endocrinol Metab 87: 1120–1128.
  Article CAS PubMed Google Scholar
• Puzianowska-Kuznicka M, Nauman A, Madej A, Tanski Z, Cheng S, Nauman J . (2000). Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma. Cancer Lett 155: 145–152.
  Article CAS PubMed Google Scholar
• Puzianowska-Kuznicka M, Pietrzak M, Turowska O, Nauman A . (2006). Thyroid hormones and their receptors in the regulation of cell proliferation. Acta Biochim Pol 53: 641–650.
  CAS PubMed Google Scholar
• Ringel MD, Hayre N, Saito J, Saunier B, Schuppert F, Burch H et al. (2001). Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res 61: 6105–6111.
  CAS PubMed Google Scholar
• Safer JD, Colan SD, Fraser LM, Wondisford FE . (2001). A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma. Thyroid 11: 281–291.
  Article CAS PubMed Google Scholar
• Sap J, Munoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A et al. (1986). The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 324: 635–640.
  Article CAS PubMed Google Scholar
• Sharpless NE, DePinho RA . (2002). p53: good cop/bad cop. Cell 110: 9–12.
  Article CAS PubMed Google Scholar
• Shen WT, Chung WY . (2005). Treatment of thyroid cancer with histone deacetylase inhibitors and peroxisome proliferator-activated receptor-gamma agonists. Thyroid 15: 594–599.
  Article CAS PubMed Google Scholar
• Suzuki H, Willingham MC, Cheng SY . (2002). Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. Thyroid 12: 963–969.
  Article CAS PubMed Google Scholar
• Suzuki H, Zhang XY, Forrest D, Willingham MC, Cheng SY . (2003). Marked potentiation of the dominant negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele. Mol Endocrinol 17: 895–907.
  Article CAS PubMed Google Scholar
• Takano T, Miyauchi A, Yoshida H, Nakata Y, Kuma K, Amino N . (2003). Expression of TRbeta1 mRNAs with functionally impaired mutations is rare in thyroid papillary carcinoma. J Clin Endocrinol Metab 88: 3447–3449.
  Article CAS PubMed Google Scholar
• Teresi RE, Waite KA . (2008). PPARgamma, PTEN, and the fight against cancer. PPAR Res 2008: 932632.
  Article PubMed PubMed Central Google Scholar
• Thormeyer D, Baniahmad A . (1999). The v-erbA oncogene (review). Int J Mol Med 4: 351–358.
  CAS PubMed Google Scholar
• Troussard AA, Costello P, Yoganathan TN, Kumagai S, Roskelley CD, Dedhar S . (2000). The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene 19: 5444–5452.
  Article CAS PubMed Google Scholar
• Troussard AA, Mawji NM, Ong C, Mui A, St -Arnaud R, Dedhar S . (2003). Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem 278: 22374–22378.
  Article CAS PubMed Google Scholar
• Turpeenniemi-Hujanen T . (2005). Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie 87: 287–297.
  Article CAS PubMed Google Scholar
• Ward JM, Ohshima M . (1986). The role of iodine in carcinogenesis. Adv Exp Med Biol 206: 529–542.
  CAS PubMed Google Scholar
• Weidner N, Semple JP, Welch WR, Folkman J . (1991). Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med 324: 1–8.
  Article CAS PubMed Google Scholar
• Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM . (1986). The c-erb-A gene encodes a thyroid hormone receptor. Nature 324: 641–646.
  Article CAS PubMed Google Scholar
• Weiss RE, Refetoff S . (2000). Resistance to thyroid hormone. Rev Endocr Metab Disord 1: 97–108.
  Article CAS PubMed Google Scholar
• Wikstrom L, Johansson C, Salto C, Barlow C, Campos Barros A, Baas F et al. (1998). Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1. EMBO J 17: 455–461.
  Article CAS PubMed PubMed Central Google Scholar
• Yen PM, Ikeda M, Brubaker JH, Forgione M, Sugawara A, Chin WW . (1994). Roles of v-erbA homodimers and heterodimers in mediating dominant negative activity by v-erbA. J Biol Chem 269: 903–909.
  CAS PubMed Google Scholar
• Ying H, Furuya F, Zhao L, Araki O, West BL, Hanover JA et al. (2006). Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone beta receptor inhibits mitotic progression. J Clin Invest 116: 2972–2984.
  Article CAS PubMed PubMed Central Google Scholar
• Ying H, Suzuki H, Furumoto H, Walker R, Meltzer P, Willingham MC et al. (2003a). Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma. Carcinogenesis 24: 1467–1479.
  Article CAS PubMed Google Scholar
• Ying H, Suzuki H, Zhao L, Willingham MC, Meltzer P, Cheng SY . (2003b). Mutant thyroid hormone receptor beta represses the expression and transcriptional activity of peroxisome proliferator-activated receptor gamma during thyroid carcinogenesis. Cancer Res 63: 5274–5280.
  CAS PubMed Google Scholar
• Zeiger MA, Saji M, Gusev Y, Westra WH, Takiyama Y, Dooley WC et al. (1997). Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice. Endocrinology 138: 3133–3140.
  Article CAS PubMed Google Scholar
• Zhang XY, Kaneshige M, Kamiya Y, Kaneshige K, McPhie P, Cheng SY . (2002). Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor. Mol Endocrinol 16: 2077–2092.
  Article CAS PubMed Google Scholar
• Zimonjic DB, Kato Y, Ying H, Popescu NC, Cheng SY . (2005). Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice. Cancer Genet Cytogenet 161: 104–109.
  Article CAS PubMed Google Scholar